Prevalence
Causes
Clinical
features
Investigations
Therapy
Prevention
Prognosis
|  |  | | Prevention |
Contrast medium nephrotoxicity
Use low-osmolality contrast media
a
particularly for high-risk patients
-
with pre-existing renal impairment
a
-
with diabetes
b
-
undergoing angiography b
Why?
-
Around 3% of patients develop nephrotoxicity following contrast media studies
b
-
Low-osmolality contrast media causes less nephrotoxicity than high-osmolality contrast media in high-risk patients.a
Low-osmolality contrast media cause less acute renal dysfunction than
high-osmolality media
| Patient |
Treatment |
Comparison |
Outcome |
CER |
OR (95% CI) |
NNT
(95% CI) |
undergoing contrast study
a
|
low-osmolality contrast media
|
high-osmolality contrast media
|
increase in Cr levels of > 44 µmol/L
at
2
days
|
3%
|
0.61 (0.48 to
0.77) |
90
(68 to
150)
|
|
|
|
|
increase in Cr levels of > 90 µmol/L
at
2
days
|
3%
|
0.44 (0.26 to
0.73) |
120
(95 to
260)
|
|
pre-existing renal impairment undergoing contrast study
|
|
|
increase in Cr levels of > 44 µmol/L
at
2
days
|
1.5%
|
0.50 (0.36 to
0.70) |
70
(55 to
120)
|
Angiography, pre-existing renal failure or insulin-dependent diabetes increase the risk of nephrotoxicity
| Patient |
Prognostic Factor |
Outcome |
CER |
RR (95% CI) |
NNF+
(95% CI) |
elderly
b
|
angiocardiography
independent
|
nephrotoxicity
at
48
hours
|
3%
|
3.44 (1.25 to
6.79) |
14
(6 to
140)
|
|
|
pre-existing renal insufficiency
independent
|
|
|
3.06 (1.29 to
5.41) |
17
(8 to
120)
|
|
|
insulin-dependent diabetes mellitus
independent
|
|
|
3.06 (1.19 to
7.80) |
17
(5 to
180)
|
|